Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash from Financing Activities (2021 - 2025)

Tenon Medical has reported Cash from Financing Activities over the past 5 years, most recently at $2.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 2315.93% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $9.0 million, down 36.36%, while the annual FY2025 figure was $9.0 million, 36.36% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.7 million at Tenon Medical, up from $59000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $14.2 million in Q2 2022 and troughed at -$179000.0 in Q4 2021.
  • A 5-year average of $3.1 million and a median of $818500.0 in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 10507.14% in 2024 and later tumbled 99.39% in 2025.
  • Year by year, Cash from Financing Activities stood at -$179000.0 in 2021, then surged by 86.03% to -$25000.0 in 2022, then soared by 5584.0% to $1.4 million in 2023, then crashed by 91.76% to $113000.0 in 2024, then surged by 2315.93% to $2.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for TNON at $2.7 million in Q4 2025, $59000.0 in Q3 2025, and -$59000.0 in Q2 2025.